Vivimed Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2018, inter alia, to consider and approve the audited Financial Results of the Company for the quarter and year ended March 31, 2018 and to consider, recommend dividend for the FY 2017 -2018, if any.In view of this, pursuant to SEBI (Prohibition of Insider Trading) Regulations and Company's Internal Code for Prevention of Insider...